Publication | Closed Access

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study

VaccinologyVaccine SafetyVaccinationInfectious Disease PreventionVaccine DevelopmentHealthy SubjectsVaccine SurveillanceImmunodeficienciesImmunologyConcomitant VaccinationVaccine TestingInfection ControlMedicineVaccine ResearchPhase 3